- Home
- Publications
-
A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.
This page provides detailed information about this publication. Please click on any text which is underlined to find more information.
- Authors
- Larah A.J. van der Meer, Myriam Harfterkamp, Gigi van de Loo-Neus, Monika Althaus, Saskia de Ruiter, Rogier Donders, Leo M.J. de Sonneville, Jan K. Buitelaar, Pieter J. Hoekstra, Nanda Rommelse
- Title
- A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.
- Journal
- Journal of Clinical Psychopharmacology
- Year
- 2013
- Month
- December
- Volume
- 33
- Issue
- 6
- Page(s)
- pp. 824-827.
- Abstract Link
- Read Abstract (New Window)
- Publication Format
- Journal Article
- Efficacy Study/Review
- Yes
- Scientific Validity
- Secondary Analysis, Randomised Trial, Placebo, Peer-Reviewed, Controlled Trial, Comparative Study
- Comments
- This is a secondary analysis of Harfterkamp M. et al. (2012).
- Keywords
- Adolescent / Secondary School Age, Atomoxetine, Attention Deficit Hyperactivity Disorder, Autism, Child/Children, Intervention, Medication, Primary / Elementary School Age, Selective Noradrenaline Re-Uptake Inhibitor
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.